Hair Analysis May Help Diagnose Cushing Syndrome
By LabMedica International staff writers Posted on 23 Feb 2017 |
Image: Research shows analyzing cortisol levels in hair close to the scalp may be a reliable diagnostic method for Cushing\'s syndrome (Photo courtesy of Professor Antonella Tosti, MD).
Cushing's syndrome is a condition that occurs as a result of exposure to high levels of cortisol for an extended period. The diagnosis of Cushing syndrome is often difficult and time-consuming, requiring 24 hours to analyze blood and urine tests, brain imaging tests, and tissue samples from sinuses at the base of the skull.
Excessive cortisol levels can also be caused when a tumor develops inside one of the body's glands, such as the pituitary or adrenal glands, although this is less common. The adrenal glands produce cortisol. Elevated cortisol levels can be triggered as a side effect of corticosteroid medications that are used to treat inflammatory diseases, such as lupus, asthma, and rheumatoid arthritis.
Scientists associated with the US National Institute of Child Health and Human Development enrolled 30 patients (26.5 ± 18.9 years, 75% female, and 75% Caucasian) with Cushing Syndrome and six patients who did not have the condition. The number of patients in the study was small, compared to studies of patients with more common disorders, because Cushing Syndrome is rare and it is difficult to recruit a large number of patients. The study participants provided hair samples divided into three equal segments.
The team analyzed diurnal serum cortisol, 24 hour urinary free cortisol corrected for body surface area (UFC/BSA), and 24 hour urinary 17-hydroxysteroids corrected for creatinine (17OHS/Cr). The investigators took 3-cm hair samples nearest to the scalp, cut into 1-cm segments (proximal, medial, and distal), which were analyzed for cortisol by enzyme immunoassay and measured as pmol cortisol/g dry hair. Hair cortisol levels were compared with laboratory testing done within previous two months of the evaluation.
The scientists reported that proximal hair cortisol was higher in Cushing syndrome patients (266.6 ± 738.4 pmol/g) than control patients (38.9 ± 25.3 pmol/g). Proximal hair cortisol was highest of all segments in 25/36 (69%) patients. Among all subjects, proximal hair cortisol was strongly correlated with UFC/BSA midnight serum cortisol and 17OHS/Cr, which trended towards significance. Hair cortisol levels closely correlated with cortisol levels in urine, blood.
The authors concluded that among the three examined hair segments; proximal hair contained the highest cortisol levels and correlated the most with the initial biochemical tests for Cushing syndrome in their study. Further studies are needed to validate proximal hair cortisol in the diagnostic workup for Cushing syndrome. Mihail Zilbermint, MD, an endocrinologist and senior author of the study said, “Our results are encouraging. We are hopeful that hair analysis may ultimately prove useful as a less invasive screening test for Cushing's syndrome or in helping to confirm the diagnosis.” The study was published on February 13, 2017, in the journal Endocrine.
Excessive cortisol levels can also be caused when a tumor develops inside one of the body's glands, such as the pituitary or adrenal glands, although this is less common. The adrenal glands produce cortisol. Elevated cortisol levels can be triggered as a side effect of corticosteroid medications that are used to treat inflammatory diseases, such as lupus, asthma, and rheumatoid arthritis.
Scientists associated with the US National Institute of Child Health and Human Development enrolled 30 patients (26.5 ± 18.9 years, 75% female, and 75% Caucasian) with Cushing Syndrome and six patients who did not have the condition. The number of patients in the study was small, compared to studies of patients with more common disorders, because Cushing Syndrome is rare and it is difficult to recruit a large number of patients. The study participants provided hair samples divided into three equal segments.
The team analyzed diurnal serum cortisol, 24 hour urinary free cortisol corrected for body surface area (UFC/BSA), and 24 hour urinary 17-hydroxysteroids corrected for creatinine (17OHS/Cr). The investigators took 3-cm hair samples nearest to the scalp, cut into 1-cm segments (proximal, medial, and distal), which were analyzed for cortisol by enzyme immunoassay and measured as pmol cortisol/g dry hair. Hair cortisol levels were compared with laboratory testing done within previous two months of the evaluation.
The scientists reported that proximal hair cortisol was higher in Cushing syndrome patients (266.6 ± 738.4 pmol/g) than control patients (38.9 ± 25.3 pmol/g). Proximal hair cortisol was highest of all segments in 25/36 (69%) patients. Among all subjects, proximal hair cortisol was strongly correlated with UFC/BSA midnight serum cortisol and 17OHS/Cr, which trended towards significance. Hair cortisol levels closely correlated with cortisol levels in urine, blood.
The authors concluded that among the three examined hair segments; proximal hair contained the highest cortisol levels and correlated the most with the initial biochemical tests for Cushing syndrome in their study. Further studies are needed to validate proximal hair cortisol in the diagnostic workup for Cushing syndrome. Mihail Zilbermint, MD, an endocrinologist and senior author of the study said, “Our results are encouraging. We are hopeful that hair analysis may ultimately prove useful as a less invasive screening test for Cushing's syndrome or in helping to confirm the diagnosis.” The study was published on February 13, 2017, in the journal Endocrine.
Latest Immunology News
- AI Predicts Tumor-Killing Cells with High Accuracy
- Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
- AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
- Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
- Testing Method Could Help More Patients Receive Right Cancer Treatment
- Groundbreaking Test Monitors Radiation Therapy Toxicity in Cancer Patients
- State-Of-The Art Techniques to Investigate Immune Response in Deadly Strep A Infections
- Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome
- New Test Could Predict Immunotherapy Success for Broader Range Of Cancers
- Simple Blood Protein Tests Predict CAR T Outcomes for Lymphoma Patients
- Cell Sorter Chip Technology to Pave Way for Immune Profiling at POC
- Chip Monitors Cancer Cells in Blood Samples to Assess Treatment Effectiveness
- Automated Immunohematology Approaches Can Resolve Transplant Incompatibility
- AI Leverages Tumor Genetics to Predict Patient Response to Chemotherapy
- World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw
- Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form